ERBB2 and breast carcinoma: To determine if a pharmacological dose of VC affects another breast cancer cell line, MCF7, an estrogen and progesterone receptor-positive with HER2/neu-negative, was tested, along with non-cancerous cell lines such as kidney HEK 293 and lung CCL205.